FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £14.39m
- £14.53m
- £1.97m
Fusion Antibodies - Holding(s) in Company
Brief: Fusion Antibodies Says Co Remains Cautiously Optimistic For FY2027
Fusion Antibodies - Year-end trading statement
Brief: Fusion Antibodies Agrees To Transfer Certain Background IP To Finn Therapeutics
Fusion Antibodies - Antibody IP transfer agreement
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Issue of Director Shares
Fusion Antibodies - Placing and Subscription to raise approx £1.4m
Brief: Fusion Antibodies Says National Cancer Institute Proposes Extension Of Collaboration Agreement
RCS - Fusion Antibodies - Mammalian Display video
Fusion Antibodies - Holding(s) in Company
Brief: Fusion Antibodies H1 Pretax Profit GBP -548 Thousand
Fusion Antibodies - Half-year Financial Report
Fusion Antibodies - Notice of Results
RCS - Fusion Antibodies - OptiMAL Library video
Brief: Fusion Antibodies Says On Track For Commercial Launch Of Optimal In December 2025
Fusion Antibodies - OptiMAL® R&D Update